Pleomorphic (Giant and/or Spindle Cell) Carcinoma of Lung Shows a High Percentage of Variant CYP1A1*2

被引：0
|
作者：
Ronald M. Przygodzki
Michael N. Koss
Timothy J. O’leary
机构：
[1] The Armed Forces Institute of Pathology,Department of Cellular Pathology
[2] The Armed Forces Institute of Pathology,Department of Genetics
[3] Department of Cellular Pathology and Genetics,Armed Forces Institute of Pathology
来源：
Molecular Diagnosis | 2001年 / 6卷 / 2期
关键词：
lung carcinoma; CYP1A1; KRAS; DNA mutation;
D O I：
10.1007/BF03262040
中图分类号：
学科分类号：
摘要：
Background: Pleomorphic carcinoma (PC) of the lung is an aggressive epithelial neoplasm composed of giant and/or spindle tumor cells and associated with short survival. Most patients are cigarette smokers. The tumor susceptibility gene P-450 1A1 (CYP1A1) is involved in the activation of polycyclic aromatic hydrocarbons, including benzo[a]pyrene, producing DNA-damaging epoxides that lead to G:C→T:A point mutations. Isoleucine (Ile)-valine (Val) and Val-Val genotypes of the CYP1A1 exon 7 polymorphism are associated with an increased risk for lung cancer in certain populations.
引用
收藏
页码：109 / 115
页数：6
相关论文
共 50 条
  • [41] Differential impact of polymorphic NAT2 and CYP1A1 to lung and laryngeal cancer.
    Cascorbi, I
    Henning, S
    Brockmoller, J
    Jahnke, V
    Loddenkemper, R
    Roots, I
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 620 - 620
  • [42] CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma
    Gajecka, M
    Rydzanicz, M
    Jaskula-Sztul, R
    Kujawski, M
    Szyfter, W
    Szyfter, K
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 574 (1-2) : 112 - 123
  • [43] Interaction of the CYP1A1 gene polymorphism and smoking in non-small cell lung cancer susceptibility
    Xie, Y. Q.
    Chen, J. M.
    Liu, Y.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 19411 - 19417
  • [44] Differential in vivo effects of α-naphthoflavone and β-naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney
    Sinal, CJ
    Webb, CD
    Bend, JR
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 1999, 13 (01) : 29 - 40
  • [45] CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from Central South China
    Feng-mao Huang
    Han-chun Chen
    Md. Asaduzzaman Khan
    Fu-lan Yang
    Xin-xing Wan
    Ai-hua Xu
    Fang-dan Ou-yang
    Dian-zheng Zhang
    Medical Oncology, 2013, 30
  • [46] CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from Central South China
    Huang, Feng-mao
    Chen, Han-chun
    Khan, Md. Asaduzzaman
    Yang, Fu-lan
    Wan, Xin-xing
    Xu, Ai-hua
    Ou-yang, Fang-dan
    Zhang, Dian-zheng
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [47] Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer
    Wright, C. M.
    Larsen, J. E.
    Colosimo, M. L.
    Barr, J. J.
    Chen, L.
    McLachlan, R. E.
    Yang, I. A.
    Bowman, R. V.
    Fong, K. M.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (01) : 152 - 159
  • [48] Fusobacterium nucleatum promotes proliferation in oesophageal squamous cell carcinoma via AHR/CYP1A1 signalling
    Yin, Haisen
    Zhang, Jianwei
    Zhang, Hanping
    Li, Qing
    Qiu, Hu
    Hong, Kunqiao
    Wang, Wei
    Xiao, Yong
    Yu, Baoping
    FEBS JOURNAL, 2023, 290 (03) : 837 - 854
  • [49] Polymorphisms in AHR, CYP1A1, and CYP2B6 genes and high environmental exposure to PCBs
    Pavuk, M.
    Cerhan, J.
    Kocan, A.
    Drobna, B.
    EPIDEMIOLOGY, 2007, 18 (05) : S92 - S93
  • [50] CYP1A1, CYP2E1 and GSTM1 genotypes as risk factors for head and neck squamous cell carcinoma (HNSCC) and allelic loss in HNSCC.
    Rybicki, BA
    Monaghan, KG
    Benninger, MS
    Feldman, GL
    Van Dyke, DL
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S120 - S120
12345